 SAN DIEGO, CA ACCESSWIRE January 23, 2023 Ensysce Biosciences, Inc. Ensysce or the Company NASDAQ:ENSC, OTC:ENSCW, a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, today announced that Chief Executive Officer, Dr. Lynn Kirkpatrick, will present a company overview at the Diamond Equity Research 2023 Virtual Emerging Growth Invitational on Wednesday, January 25th, 2023, at 12:20 p.m. Eastern Time. 